<scp>STAT6</scp> suppression prevents bleomycin‐induced dermal fibrosisJingjing Huang, Tingting Mills|The FASEB Journal|2023Cited by 14
LBA12 Efficacy and safety of IBI351 (GFH925), a selective KRASG12C inhibitor, monotherapy in patients (pts) with advanced non-small cell lung cancer (NSCLC): Initial results from a registrational phase II studyQing Zhou, Yi‐Long Wu, Da Huang et al.|Annals of Oncology|2023Cited by 10